Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2024 Dec;103(12):4989-5005.
doi: 10.1007/s00277-024-06052-9. Epub 2024 Oct 23.

Aplastic Anemia in the light of the COVID-19 pandemic: infection, vaccination, and pathophysiologic mechanisms

Affiliations
Review

Aplastic Anemia in the light of the COVID-19 pandemic: infection, vaccination, and pathophysiologic mechanisms

Nelson Luis Cahuapaza-Gutierrez. Ann Hematol. 2024 Dec.

Abstract

Patients infected with SARS-CoV-2 and vaccinated against COVID-19 could develop aplastic anemia (AA). Comprehensive review and analysis were conducted through a selective literature search in PubMed, Scopus, EMBASE, and Web of Science. For this analysis, 26 studies were included, comprising 16 case reports, 7 case series, and 3 observational studies, totaling 53 patients. The causes of acquired or idiopathic AA are diverse; this review presents recent findings, including possible new etiologies such as SARS-CoV-2 infection and COVID-19 vaccines. This possible association is explored, addressing the existing gap, and aiming to improve daily medical practice. This article reviews the relationship between AA and SARS-CoV-2 infection, as well as COVID-19 vaccines, analyzing cases of de novo occurrence and relapses of AA. Although a definitive mechanistic link has not yet been established, possible underlying pathophysiological mechanisms are explored.

Keywords: Aplastic Anemia; COVID-19; COVID-19 Vaccines; SARS-CoV-2; SARS-CoV-2 Vaccines (Source: Medical Subject Headings of the National Library of Medicine (MeSH NLM)).

PubMed Disclaimer

Conflict of interest statement

Declarations. Ethics approval: This is a review study. No ethical approval is required. Competing interest: The authors declare no competing interests.

Similar articles

References

    1. Hadj Hassine I (2022) Covid-19 vaccines and variants of concern: a review. Rev Med Virol 32(4):e2313 - PubMed
    1. WHO Coronavirus (COVID-19) Dashboard [Internet]. [citado 3 de abril de 2023]. Disponible en: https://covid19.who.int. Accessed 9 Oct 2024
    1. Gupta A, Madhavan MV, Sehgal K, Nair N, Mahajan S, Sehrawat TS et al (2020) Extrapulmonary manifestations of COVID-19. Nat Med 26(7):1017–1032 - PubMed
    1. Alahyari S, Moradi M, Rajaeinejad M, Jalaeikhoo H (2022) Post-COVID-19 hematologic complications: a systematic review. Expert Rev Hematol 15(6):539–546 - PubMed
    1. Beladiya J, Kumar A, Vasava Y, Parmar K, Patel D, Patel S et al (2024) Safety and efficacy of COVID-19 vaccines: a systematic review and meta-analysis of controlled and randomized clinical trials. Rev Med Virol 34(1):e2507 - PubMed

Substances

LinkOut - more resources